Cleared Traditional

K130225 - QUASAR C100, BABY QUASAR PLUS, QUASAR MD PLUS (FDA 510(k) Clearance)

Also includes:
WRINKLE REDUCTION DEVICE

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K130225 · Silverbay, LLC, D/B/A Quasar Bio-Tech · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
163d
Days
Class 2
Risk

K130225 is an FDA 510(k) clearance for the QUASAR C100, BABY QUASAR PLUS, QUASAR MD PLUS. Classified as Light Based Over The Counter Wrinkle Reduction (product code OHS), Class II - Special Controls.

Submitted by Silverbay, LLC, D/B/A Quasar Bio-Tech (Coralville, US). The FDA issued a Cleared decision on July 11, 2013 after a review of 163 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Silverbay, LLC, D/B/A Quasar Bio-Tech devices

Submission Details

510(k) Number K130225 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 29, 2013
Decision Date July 11, 2013
Days to Decision 163 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
49d slower than avg
Panel avg: 114d · This submission: 163d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OHS Light Based Over The Counter Wrinkle Reduction
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition Use Of Light Based Treatment To Reduce Wrinkles On The Body In General Or Specific Anatomical Locations Depending On The Information Provided.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - OHS Light Based Over The Counter Wrinkle Reduction

All 149
Devices cleared under the same product code (OHS) and FDA review panel - the closest regulatory comparables to K130225.
myLEDmask 2 (MJ-144)
K260415 · Light Tree Ventures Europe B.V. · May 2026
LED FACIAL MASK (MJ-66DB, MK-99, MK-99A, MK-99M, MJ-66C)
K260150 · NOOANCE · Apr 2026
LED Light Therapy Masks (LumiLips FAC07NA)
K260202 · Guangdong Newdermo Biotech Co., Ltd. · Mar 2026
LED Light Therapy Mask (Models: T2, RLD10)
K254079 · Shenzhen Desida Technology Co., Ltd. · Mar 2026
Ulike Reglow Light Therapy Device (UM10)
K260511 · Shenzhen Ulike Smart Electronics Co., Ltd. · Mar 2026
LED Therapy Light (COB1400, HP1800PRO)
K253874 · Shenzhen Hanhua Opto Co., Ltd. · Mar 2026